Neuro Pathways: A Cleveland Clinic Podcast for Medical Professionals
Ketamine Research for Treatment-Resistant Depression (Early Work Through Current State)
November 01, 2020
Roughly one in 10 Americans takes an antidepressant to aid in the debilitating symptoms of clinical depression, but for some medications don’t work. In this episode, Amit Anand, MD, discusses the evolving therapies for treatment-resistant depression, including ketamine and esketamine.
A Cleveland Clinic podcast for medical professionals exploring the latest research discoveries and clinical advances in the fields of neurology, neurosurgery, neurorehab and psychiatry. Learn how the landscape for treating conditions of the brain, spine a
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast